-

Milliman analysis: Corporate pension funded ratio improves in January to new 27-month high

Milliman 100 PFI plans start 2025 with $12 billion funded status improvement

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., a premier global consulting and actuarial firm, today released the results of the latest monthly Milliman 100 Pension Funding Index (PFI), which analyzes the 100 largest U.S. corporate pension plans.

The funded ratio of the Milliman PFI plans climbed in January from 104.8% as of December 31, 2024, to 105.8% as of January 31, 2025. The rise was due in part to a 1.19% monthly market return, which surpassed the expected 0.52% and lifted plan assets by $9 billion to $1.308 trillion at month’s end. Meanwhile, a slight increase of 1 basis point in the monthly discount rate, to 5.60% for the period, reduced plan liabilities from $1.240 trillion at the end of last year to $1.237 trillion as of January 31.

“The funded status surplus of the Milliman 100 plans reached a 27-month high at the end of January—the perfect start to the year as plan liabilities declined while plan assets grew after market gains exceeded expectations,” said Zorast Wadia, author of the PFI. “With Fed rate cuts still a possibility this year, prudent asset-liability management remains a key directive for plan sponsors to preserve the funded status gains achieved thus far.”

Looking forward, under an optimistic forecast with rising interest rates (reaching 6.15% by the end of 2025 and 6.75% by the end of 2026) and asset gains (10.4% annual returns), the funded ratio would climb to 117% by the end of 2025 and 130% by the end of 2026. Under a pessimistic forecast (5.05% discount rate at the end of 2025 and 4.45% by the end of 2026 and 2.4% annual returns), the funded ratio would decline to 97% by the end of 2025 and 88% by the end of 2026.

To view the complete Pension Funding Index, go to www.milliman.com/pfi. To see Milliman’s full range of annual Pension Funding Studies, go to https://www.milliman.com/en/retirement-and-benefits/pension-funding-studies. To receive regular updates of Milliman’s pension funding analysis, contact us at pensionfunding@milliman.com.

About Milliman

Milliman leverages deep expertise, actuarial rigor, and advanced technology to develop solutions for a world at risk. We help clients in the public and private sectors navigate urgent, complex challenges—from extreme weather and market volatility to financial insecurity and rising health costs—so they can meet their business, financial, and social objectives. Our solutions encompass insurance, financial services, healthcare, life sciences, and employee benefits. Founded in 1947, Milliman is an independent firm with offices in major cities around the globe. Visit us at milliman.com.

Contacts

Zorast Wadia
Milliman, Inc.
Tel: +1 646 473 3315
zorast.wadia@milliman.com

Milliman, Inc.


Release Versions

Contacts

Zorast Wadia
Milliman, Inc.
Tel: +1 646 473 3315
zorast.wadia@milliman.com

More News From Milliman, Inc.

Milliman analysis: Corporate pension funding levels rise for eighth consecutive month in November

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., a premier global consulting and actuarial firm, today released its monthly Milliman 100 Pension Funding Index (PFI), which analyzes the 100 largest U.S. corporate pension plans. During November, the PFI funded ratio edged up from 107.0% at the end of October to 107.1% as of November 30. A 1-basis-point rise in discount rates, to 5.34% in November, drove this result. It shaved $3 billion from plan liabilities and offset market returns of only 0.44%. As o...

Milliman analysis: Public pension funding rises in October to highest level in study history

SEATTLE--(BUSINESS WIRE)--Milliman, Inc., a premier global consulting and actuarial firm, today released the latest results of its Public Pension Funding Index (PPFI), which analyzes data from the nation’s 100 largest public defined benefit plans. For the seventh straight month, the PPFI funded ratio improved in October, rising from 85.4% as of September 30 to 86.3% as of October 31, surpassing the previous high-water mark of 85.5% set at the end of 2021. Another month of strong investment retu...

Milliman CareFlowIQ Strengthens Real-Time Clinical Intelligence Platform with Expanded Medication History from Surescripts

SEATTLE--(BUSINESS WIRE)--Milliman CareFlowIQ™, transforming fragmented healthcare data into trusted, proven, evidence-based insights for informed decision-making, announces expanded medication reconciliation capabilities from Surescripts, the nation's leading health intelligence network. With Surescripts Medication History for Reconciliation, CareFlowIQ will give healthcare providers unprecedented access to comprehensive, real-time patient medication history. This data enhances whole-patient v...
Back to Newsroom